RecruitingNot ApplicableNCT06791603

The Impact of Social Media-delivered Chemotherapy Side Effects Education for Breast Cancer Patients Receiving Chemotherapy

The Impact of Social Media-delivered Chemotherapy-related Side Effects Education for Breast Cancer Patients Receiving First Time Chemotherapy


Sponsor

Taipei Medical University Shuang Ho Hospital

Enrollment

100 participants

Start Date

Jan 6, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

The goal of this clinical trial is to learn if a standardized pharmacists-provided education module by social media can improve patients' knowledge of chemotherapy-related side effects. The main questions it aims to answer is: • Do patients who received a standardized pharmacists-provided education module by social media improve their knowledge of chemotherapy-related side effects? Researchers will compare standardized chemotherapy education +video (experimental group) versus chemotherapy handouts (control group). Participants will: * Received standardized chemotherapy education + video or chemotherapy handouts at the first and second chemotherapy section. * Fill out a questionnaire for outcomes assessment.


Eligibility

Min Age: 18 Years

Inclusion Criteria2

  • Breast cancer patients aged 18 or older undergoing their first chemotherapy.
  • Possess a smartphone and are able to watch videos on it.

Exclusion Criteria3

  • Unable to read or complete questionnaires in Chinese.
  • Cognitive impairments.
  • Pregnant women.

Interventions

OTHERStandardized chemotherapy education + video

Videos will be provided with patients and they will watch videos during the visit. The information regarding the prevention and management of side effects and further instructions when to visit hospital. Patients will have access to videos and watch videos after leaving the hospital for the entire treatment course


Locations(1)

Shuang Ho Hospital

New Taipei City, Taiwan

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06791603